Cargando…
A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies
BACKGROUND: Stromal derived factor-1α (SDF-1α/CXCL12) is a chemokine that is up-regulated in diseases characterised by tissue hypoxia, including myocardial infarction, ischaemic cardiomyopathy and remote ischaemic conditioning (RIC), a technique of cyclical, non-injurious ischaemia applied remote fr...
Autores principales: | Bromage, Daniel I., Taferner, Stasa, Pillai, Mahesh, Yellon, Derek M., Davidson, Sean M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381782/ https://www.ncbi.nlm.nih.gov/pubmed/28379992 http://dx.doi.org/10.1371/journal.pone.0174447 |
Ejemplares similares
-
Stromal cell-derived factor-1α signals via the endothelium to protect the heart against ischaemia-reperfusion injury
por: Bromage, Daniel I., et al.
Publicado: (2019) -
Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium()
por: Bromage, Daniel I., et al.
Publicado: (2014) -
The role of PI3Kα isoform in cardioprotection
por: Rossello, Xavier, et al.
Publicado: (2017) -
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4
por: Malik, A., et al.
Publicado: (2015) -
Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy
por: Ziff, Oliver J, et al.
Publicado: (2018)